icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV GT 1 and HIV-1
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
P Buggisch1, A Moreno2, V Isakov3, L Backus4, D Ain5, P Ruane5, J Gonzalez-Garcia6, S Naik7, S Mehta7, J Lee7, M Mertens7, J Llewellyn7, M Natha7, K Kersey7, A Osinusi7, J Slim8, K Zhdanov9, J Berenguer10, S Zeuzem11
1Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany; 2Hospital Ramon y Cajal Infectious Diseases, Madrid Spain; 3Institute of Nutrition of Russian Academy of Medical Sciences, Moscow, Russian Federation; 4Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA; 5Ruane Medical and Liver Health Institute, Los Angeles, CA, USA; 6Hospital Universitario La Paz/IdiPaz Internal Medicine, Madrid Spain; 7Gilead Sciences, Foster City, CA, USA; 8Saint Michaels Medical Center, Newark, NJ, USA; 9Military Medical Academy, St. Petersburg, Russian Federation; 10Hospital General Universitario Gregorio Maranon/IiSGM Infectious Diseases, Madrid, Spain;11Johann Wolfgang Goethe University Medical Center, Frankfurt, Germany.